RUS  ENG
Full version
JOURNALS // Mendeleev Communications // Archive

Mendeleev Commun., Forthcoming paper (Mi mendc7593)

Just Accepted

Anticancer activity of new 5-(2-oxodihydrobenzimidazolyl)pyrrole-3-carbonitriles, pharmacophore analogues of opnurasib

V. R. Galimullinaa, D. V. Ivanovaa, V. V. Syakaeva, O. B. Babaevaa, I. Kh. Rizvanova, A. S. Bunevb, D. O. Shkilc, A. A. Zakharchukc, O. G. Sinyashina, K. V. Balakinc, V. A. Mamedova

a A. E. Arbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center of the Russian Academy of Sciences, 420088 Kazan, Russian Federation
b Medicinal Chemistry Center, Togliatti State University, 445020 Togliatti, Russian Federation
c Moscow Institute of Physics and Technology (National Research University), 141700 Dolgoprudny, Moscow Region, Russian Federation

Keywords: acrylamides, a-(benzimidazol-1-yl)pyrroles, α-(piperazino)pyrroles, pyrrole-3-carbonitriles, molecular docking, KRAS inhibitors.

Received: 08.07.2026
Revised: 02.09.2026
Accepted: 12.10.2026
Published online: 15.10.2026

Language: English

DOI: 10.71267/mencom.8142



© Steklov Math. Inst. of RAS, 2026